SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
A coalition of businesses, nonprofits and San Diego real estate professionals has banded together to prevent prescription drug theft at open houses. Key to the group’s mission is ensuring the safe use, storage and disposal of prescription drugs.
BIOTECH: Tesaro Will Develop 3 of Co.’s Drugs
AnaptysBio Inc., a player in the hot field of cancer immunotherapy, has attracted $17 million up front in a drug development rights deal with Massachusetts-based Tesaro Inc. that could ultimately be worth hundreds of millions more.
BIOTECH: No Narrow Niches For Maravai and Local CEO
Chicago private equity firm GTCR is doling out up to $300 million to launch Maravai Life Sciences Inc. in San Diego, tapping the expertise of former Gen-Probe Inc. executives Carl Hull and Eric Tardif to lead a new, acquisition-driven venture.
Billionaire Virgin Group founder Richard Branson will be the keynote speaker at the 2014 Bio International Convention in San Diego — one of the nation’s largest biotechnology forums that attracts more than 15,000 attendees each year.
San Diego staffing firm AMN Healthcare Services Inc. will invest $5 million in a series of staged payments to San Francisco telepharmacy company PipelineRx.
San Diego-based BioMed Realty Trust Inc. (NYSE: BMR) has declared a first-quarter 2014 dividend of 25 cents per share of common stock, equivalent to $1 per share on an annualized basis.
Irish specialty drugmaker Mallinckrodt PLC has completed the $1.4 billion purchase of San Diego-based Cadence Pharmaceuticals Inc. The deal was announced initially in February.
Former Gen-Probe executives Carl Hull and Eric Tardif have been tasked by a Chicago-based private equity firm to launch a life sciences company in San Diego aimed at acquiring other companies and with a few hundred million dollars at the ready.
U.S. Reps. Susan Davis and Scott Peters, both Democrats from San Diego, gathered with a group of the region’s medical research stakeholders to solicit Congress to increase funding for the National Institutes of Health, which funds much of the medical research taking place in this area.
Kaiser Permanente will open a new medical office building in Oceanside on March 17.
AnaptysBio Inc. could receive up to $125 million from a new partnership with Massachusetts cancer drugmaker Tesaro Inc., including $17 million upfront
AnaptysBio Inc. could receive up to $125 million from a new partnership with Massachusetts cancer drugmaker Tesaro Inc., including $17 million upfront.
Happy World Sleep Day.
Things aren’t looking great for Zogenix Inc. nor its flagship drug, the powerful narcotic painkiller Zohydro. The company’s stock recently plummeted on news that a competitor just might have built a better mousetrap — drug — and could soon emerge on the market.
BIOTECH: Proactive Patient Got to Work on New Mobility Device
Extreme athlete Kim Goodsell has a bevy of health conditions that could severely limit her ability to walk. But with research, ingenuity and sheer pluck she has taken charge of her own health — and launched a new company as a result.